Cargando…

Fingolimod: Rebound effect in the form of exacerbation of COVID-19: case report

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8178044/ http://dx.doi.org/10.1007/s40278-021-96880-9

Ejemplares similares

Severe rebound after cessation of fingolimod treated with ocrelizumab with coincidental transient aggravation: report of two cases
por: Schmidt, Stephan, et al.
Publicado: (2019)

Sensory-Neural Hearing Loss as an Early Rebound Relapse after Fingolimod Cessation in Multiple Sclerosis
por: Naser Moghadasi, Abdoreza, et al.
Publicado: (2020)

Dexamethasone: Rebound of COVID-19-pneumonia: case report
Publicado: (2021)

Ibrutinib: Rebound effect in the form of respiratory deterioration following the discontinuation of ibrutinib: case report
Publicado: (2021)

Dramatic rebounds of MS during pregnancy following fingolimod withdrawal
Publicado: (2018)

Dramatic rebounds of MS during pregnancy following fingolimod withdrawal
por: Novi, Giovanni, et al.
Publicado: (2017)

Fingolimod Rebound: A Review of the Clinical Experience and Management Considerations
por: Barry, Brian, et al.
Publicado: (2019)

Fingolimod: Lymphopenia and COVID-19 infection complicated by pneumonia: case report
Publicado: (2020)

Methylprednisolone: Rebound effect in the form of worsening of inflammatory markers, fever and renal function: case report
Publicado: (2021)

Age-dependent rebound in asthma exacerbations after COVID-19 lockdown
por: Hazan, Guy, et al.
Publicado: (2022)

Colchicine/covid-19-vaccine-pfizer-biontech/ibuprofen: Acute pericarditis, rebound effect in the form of acute pericarditis and lack of efficacy: case report
Publicado: (2022)

Case Report: Persisting Lymphopenia During Neuropsychiatric Tumefactive Multiple Sclerosis Rebound Upon Fingolimod Withdrawal
por: Koska, Valeria, et al.
Publicado: (2021)

Case Report: Severe rebound after withdrawal of fingolimod in a patient with neuromyelitis optica spectrum disorder
por: Lin, Wei, et al.
Publicado: (2023)

Methylprednisolone: Rebound pneumonia: case report
Publicado: (2022)

Multiple drugs: DRESS-syndrome and rebound effect: case report
Publicado: (2022)

Pneumonia rebound after stopping steroid in a patient with COVID‐19: A case report
por: Chen, Po‐Hao, et al.
Publicado: (2021)

Remdesivir: Rebound effect in the form of SARS-CoV-2 infection following off label use: 2 case reports
Publicado: (2022)

Dexamethasone: Worsening of respiratory failure following rebound effect: case report
Publicado: (2022)

Mepolizumab/omalizumab/triamcinolone: Lack of efficacy and rebound effect: case report
Publicado: (2022)

Proxalutamide for the treatment of COVID‐19 rebound following Paxlovid treatment: Report of four cases and review of the literature
por: Yang, Da‐Wei, et al.
Publicado: (2023)

Azithromycin/dexamethasone/prednisone: Lack of efficacy, off label use and rebound effect in the form of worsening of subacute thyroiditis: 3 case reports
Publicado: (2022)

Mesalazine/prednisolone: Perimyocarditis, rebound effect and lack of efficacy: 2 case reports
Publicado: (2021)

Multiple drugs: Serum sickness-like reaction and rebound effect: case report
Publicado: (2022)

Methotrexate: COVID-19-respiratory-infection and rebound effect with anti-neutrophil cytoplasmic antibodies (ANCA) associated vasculitis: case report
Publicado: (2021)

Heparin: Masking of overt disseminated intravascular coagulation, activated partial thromboplastin time prolonged and rebound effect in the form of coagulation disorders: case report
Publicado: (2020)

Fingolimod: Type 2 second degree atrioventricular block: case report
Publicado: (2021)

Cryptosporidiosis after treatment with fingolimod: a case report and pharmacovigilance review
por: Martinot, M., et al.
Publicado: (2020)

Ruxolitinib: Rebound effect manifested as acute hypoxaemic respiratory failure: 3 case reports
Publicado: (2021)

Ipilimumab/nivolumab/prednisolone: Nephritis and rebound renal failure: case report
Publicado: (2021)

Neonatal rebound hyperkalemia associated with ritodrine alone: a case report
por: Osumi, Keita, et al.
Publicado: (2021)

Iloprost: Diarrhoea, rebound tachycardia and worsening of symptoms: 3 case reports
Publicado: (2020)

Mycophenolate-mofetil/sulfasalazine: Diarrhoea, nausea and urticaria rebound: case report
Publicado: (2022)

Life-threatening asthma attack during prolonged fingolimod treatment: case report
por: Zecca, Chiara, et al.
Publicado: (2014)

Retinal hemorrhages following fingolimod treatment for multiple sclerosis; a case report
por: Ueda, Naoko, et al.
Publicado: (2015)

Fingolimod: Severe acute respiratory syndrome coronavirus-2 infection: case report
Publicado: (2020)

Severe COVID-19 infection in a patient with multiple sclerosis treated with fingolimod
por: Foerch, Christian, et al.
Publicado: (2020)

Clinical Characteristics of Retroviral Rebound Syndrome: A Case Report and Literature Review
por: Akagi, Yu, et al.
Publicado: (2023)

COVID-19 rebound after oral treatment in a nursing home facility: A case series
por: Betrosian, Alex P., et al.
Publicado: (2022)

Atypical molluscum contagiosum on multiple sclerosis patients treated with fingolimod: A case report
por: Cheraghmakani, Hamed, et al.
Publicado: (2022)

Fingolimod induced fulminant liver failure requiring liver transplantation: A case report
por: Caliskan, Ali Riza, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_iu305c2kllh3kee9jf7s2ua35o